BOC Sciences provides a wide range of research chemicals and biochemicals including inhibitors, building blocks, GMP Products, impurities and metabolites, APIs for Veterinary, Natural Compounds, ADCs, Stem Cell Molecule and chiral compounds.
| Product | Description | |
|---|---|---|
| Daunorubicin-[d3] | Daunorubicin-[d3], a meticulously stable isotope-enriched rendition of Daunorubicin, is an esteemed anthracycline antibiotic extensively employed in the research of diverse cancer modalities, encompassing acute myeloid leukemia, lymphomas and solid tumors. Synonyms: Daunorubicin-d3. Molecular formula: C27H26D3NO10. Mole weight: 530.54. |  |
| Daunorubicin hydrochloride EP Impurity E | Daunorubicin EP Impurity E is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: Daunorubicin Impurity E; (8S,10S)-6,8,10,11-Tetrahydroxy-8-[(1RS)-1-hydroxyethyl]-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione; Daunorubicinol aglycone (Mixture of Diastereomers); Dihydrodaunomycinone (Mixture of Diastereomers); (8S,10S)-7,8,9,10-Tetrahydro-6,8,10,11-tetrahydroxy-8-(1-hydroxyethyl)-1-methoxy-5,12-naphthacenedione; 5,12-Naphthacenedione, 7,8,9,10-tetrahydro-6,8,10,11-tetrahydroxy-8-(1-hydroxyethyl)-1-methoxy-, (8S,10S)-; Daunorubicin EP Impurity E; Daunorubicin hydrochloride Impurity E. Grade: ≥95%. Molecular formula: C21H20O8. Mole weight: 400.38. | |
| Daunorubicin Impurity 1 | Daunorubicin Impurity 1 is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: 2,3,6-trideoxy-3-(trifluoroacetamido)-alpha-L-lyxo-hexopyranose; 2,3,6-trideoxy-3-(trifluoroacetamido)-L-lyxo-hexose; N-trifluoroacetyl-α,β-daunosamine; N-trifluoroacetyl-L-daunosamide; N-(trifluoroacetyl)daunosamine. CAS No. 51996-45-3. Molecular formula: C8H12F3NO4. Mole weight: 243.18. | |
| Daunorubicin Impurity 2 | Daunorubicin Impurity 2 is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: 2,3,6-Trideoxy-1,4-bis-O-(4-nitrobenzoyl)-3-[(trifluoroacetyl)amino]-α-L-lyxo-hexopyranose; α-L-lyxo-Hexopyranose, 2,3,6-trideoxy-3-[(2,2,2-trifluoroacetyl)amino]-, 1,4-bis(4-nitrobenzoate); (2S,4S,5S,6S)-6-methyl-4-(2,2,2-trifluoroacetamido)tetrahydro-2H-pyran-2,5-diyl bis(4-nitrobenzoate); α-L-lyxo-Hexopyranose, 2,3,6-trideoxy-3-[(trifluoroacetyl)amino]-, 1,4-bis(4-nitrobenzoate). CAS No. 63700-24-3. Molecular formula: C22H18F3N3O10. Mole weight: 541.39. | |
| Daunorubicin Impurity 3 Dihydrochloride | Daunorubicin Impurity 3 Dihydrochloride is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: Daunorubicin Impurity 3 DiHCl; 5,12-Naphthacenedione, 9-acetyl-7,9-bis[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,11-dihydroxy-, dihydrochloride, (7S-cis)-. CAS No. 99457-12-2. Molecular formula: C32H38N2O11.2HCl. Mole weight: 699.57. | |
| Daunorubicin Impurity 7 | Daunorubicin Impurity 7 is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: (7S,9S)-7-[(2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyloxan-2-yl]oxy-9-(2-bromo-1,1-diethoxyethyl)-6,9,11-trihydroxy-4-methoxy-8,10-dihydro-7H-tetracene-5,12-dione; Doxorubicin Impurity 15; (8S-cis)-10-[(3-Amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-diethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-8-(2-bromo-1,1-diethoxyethyl)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-, (8S-cis)-. CAS No. 131086-18-5. Molecular formula: C31H38BrNO11. Mole weight: 680.55. | |
| Daunorubicin Impurity 8 | Daunorubicin Impurity 8 is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: (8S,10S)-8-acetyl-10-(((2R,4S,5S,6S)-4-amino-5-(benzyloxy)-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione; (8S,10S)-8-Acetyl-10-[[3-amino-2,3,6-trideoxy-4-O-(phenylmethyl)-α-L-lyxo-hexopyranosyl]oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-1-methoxy-5,12-naphthacenedione. Grade: ≥95%. CAS No. 1010447-40-1. Molecular formula: C34H35NO10. Mole weight: 617.65. | |
| Daunorubicinol | Daunorubicinol, a metabolite of Daunorubicin, is an anthracycline antineoplastic antibiotic with therapeutic effects similar to those of doxorubicin. Synonyms: Daunorubicin Impurity B ((1S)-isomer); 5,12-Naphthacenedione, 10-((3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy)-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-((1S)-1-hydroxyethyl)-1-methoxy-, (8S,10S)-; 13-Dihydrodaunorubicin; Duborimycin; Leukaemomycin D; (13S)-13-Dihydrodaunorubicin; (1S,3S)-3,5,12-Trihydroxy-3-[(1S)-1-hydroxyethyl]-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl-3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside; Daunomycinol; Dihydrodaunomycin; Antibiotic 20-798RP; 13-Dihydrodaunomycin. Grade: >95%. CAS No. 28008-55-1. Molecular formula: C27H31NO10. Mole weight: 529.54. | |
| Daunorubicinol-[d3] | Daunorubicinol-[d3]. Synonyms: Daunorubicinol-d3. Molecular formula: C27H28D3NO10. | |
| Daunorubicinol formate salt (mixture of diastereoisomers) | Daunorubicinol formate salt (mixture of diastereoisomers) is an impurity of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: (8S,10S)-10-(((2R,4S,5S,6S)-4-amino-5-hydroxy-6-methyltetrahydro-2H-pyran-2-yl)oxy)-6,8,11-trihydroxy-8-((S)-1-hydroxyethyl)-1-methoxy-7,8,9,10-tetrahydrotetracene-5,12-dione formate; 13-Dihydrodaunorubicin formate; Duborimycin formate; Leukaemomycin D formate; (1S,3S)-3,5,12-Trihydroxy-3-[(1R)-1-hydroxyethyl]-10-methoxy-6,11-dioxo-1,2,3,4,6,11-hexahydro-1-tetracenyl 3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranoside formate (1:1); 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-[(1R)-1-hydroxyethyl]-1-methoxy-, (8S,10S)-, formate (1:1). Grade: 95%. Molecular formula: C28H33NO12. Mole weight: 575.57. | |
| Daunorubicinol hydrochloride | Daunorubicinol Hydrochloride is a metabolite of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-, hydrochloride, [8S-[8α,8(R*),10α]]-; 13-Dihydrodaunorubicin Hydrochloride; Duborimycin Hydrochloride; Leukaemomycin D Hydrochloride; L-lyxo-Hexopyranoside, 1,2,3,4,6,11-hexahydro-3,5,12-trihydroxy-3-(1-hydroxyethyl)-10-methoxy-6,11-dioxo-1-naphthacenyl 3-amino-2,3,6-trideoxy-, hydrochloride, (1S,3S)-α-; 13-Dihydrodaunomycin hydrochloride; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-[(1S)-1-hydroxyethyl]-1-methoxy-, hydrochloride (1:1), (8S,10S)-; Antibiotic RP 20798; Antibiotic 20798 RP; Dihydrodaunomycin hydrochloride; NSC 180510. Grade: ≥95%. CAS No. 28008-53-9. Molecular formula: C27H32ClNO10. Mole weight: 566.00. | |
| Daunorubicinol TFA | Daunorubicinol TFA is a metabolite of Daunorubicin, which is an anthracycline antibiotic used in the treatment of acute myeloid and lymphocytic leukemia, with adverse reactions such as cardiotoxicity and bone marrow suppression. Synonyms: 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-(1-hydroxyethyl)-1-methoxy-, trifluoroacetic acid, [8S-[8α,8(R*),10α]]-; 13-Dihydrodaunorubicin trifluoroacetic acid; Duborimycin trifluoroacetic acid; Leukaemomycin D trifluoroacetic acid; 13-Dihydrodaunomycin trifluoroacetic acid; 5,12-Naphthacenedione, 10-[(3-amino-2,3,6-trideoxy-α-L-lyxo-hexopyranosyl)oxy]-7,8,9,10-tetrahydro-6,8,11-trihydroxy-8-[(1S)-1-hydroxyethyl]-1-methoxy-, trifluoroacetic acid (1:1), (8S,10S)-. Molecular formula: C27H31NO10.C2HF3O2. Mole weight: 643.57. | |
| Daxdilimab | Daxdilimab is a human anti-ILT7 monoclonal antibody. Daxdilimab binds to ILT7 on the surface of pDCs, which leads to the depletion of these cells and inhibits inflammation in a variety of autoimmune conditions. Synonyms: MEDI7734; VIB7734; HZN-7734. CAS No. 2245966-28-1. | |
| Dazonone | Dazonone is a specific PDE III inhibitor. Synonyms: 6-Chloro-3-methyl-3,5-dihydroimidazo[2,1-b]quinazolin-2(1H)-one. Grade: 95%. CAS No. 105622-85-3. Molecular formula: C11H10ClN3O. Mole weight: 235.67. | |
| Dazoxiben | Dazoxiben is a potent, selevtive and orally active inhibitor of thromboxane (TX) synthase, which has potential effects in patients with Raynaud's syndrome. Synonyms: Dazoxiben free base. Grade: 98%. CAS No. 78218-09-4. Molecular formula: C12H12N2O3. Mole weight: 232.24. | |
| Dazoxiben hydrochloride | Dazoxiben is a potent, selevtive and orally active inhibitor of thromboxane (TX) synthase, which has potential effects in patients with Raynaud's syndrome. Synonyms: Dazoxiben HCl. CAS No. 74226-22-5. Molecular formula: C12H13ClN2O3. Mole weight: 268.69. | |
| Dazucorilant | Dazucorilant is a glucocorticoid receptor antagonist. Synonyms: {(4aR)-1-(4-fluorophenyl)-6-[4-(trifluoromethyl)benzene-1-sulfonyl]-1,4,5,6,7,8-hexahydro-4aH-pyrazolo[3,4-g]isoquinolin-4a-yl}(pyridin-2-yl)methanone; (R)-(1-(4-fluorophenyl)-6-((4-(trifluoromethyl)phenyl)sulfonyl)-1,4,5,6,7,8-hexahydro-4aH-pyrazolo[3,4-g]isoquinolin-4a-yl)(pyridin-2-yl)methanone. CAS No. 1496508-34-9. Molecular formula: C29H22F4N4O3S. Mole weight: 582.58. | |
| DB07268 | DB07268 is a potent and selective JNK1 inhibitor. It has some degree of selectivity over quite a few kinases with the exceptions of CHK1, CK2, and PLK. Synonyms: DB07268; DB-07268; DB 07268. Grade: >98%. CAS No. 929007-72-7. Molecular formula: C17H15N5O2. Mole weight: 321.33. | |
| DB1976 | DB1976 is a selenophene analog of DB270 and a potent and cell-permeable fully efficacious transcription factor PU.1 inhibitor. It potently inhibits PU.1 binding and strongly inhibits the PU.1/DNA complex in vitro. DB1976 has apoptosis-inducing effect. Synonyms: 2,2'-(Selenophene-2,5-diyl)bis(1H-benzo[d]imidazole-6-carboximidamide); DB-1976; DB-1976. CAS No. 1557397-51-9. Molecular formula: C20H16N8Se. Mole weight: 447.35. | |
| DB1976 dihydrochloride | DB1976 is a selenophene analog of DB270 and a potent and cell-permeable fully efficacious transcription factor PU.1 inhibitor. It potently inhibits PU.1 binding and strongly inhibits the PU.1/DNA complex in vitro. DB1976 has apoptosis-inducing effect. Synonyms: DB1976 dihydrochloride; DB1976 (dihydrochloride); 2369663-93-2; DB1976 hydrochloride; DB1976 (hydrochloride); AKOS040732928; HY-135797A; CS-0114127; 2-[5-(6-carbamimidoyl-1H-benzimidazol-2-yl)selenophen-2-yl]-3H-benzimidazole-5-carboximidamide; dihydrochloride. Grade: ≥98%. CAS No. 2369663-93-2. Molecular formula: C20H18Cl2N8Se. Mole weight: 520.28. | |
| DB2115 tertahydrochloride | DB2115 tertahydrochloride is a potent inhibitor of myeloid master regulator PU.1. CAS No. 1366126-19-3. Molecular formula: C32H34Cl4N8O2. Mole weight: 704.48. | |
| DB2313 | DB2313 is a potent inhibitor of the essential transcriptional factor PU.1 with IC50 value of 14 nM. Synonyms: 2,2'-((((2-Fluoro-1,3-phenylene)bis(methylene))bis(oxy))bis(4,1-phenylene))bis(N-isopropyl-1H-benzo[d]imidazole-6-carboximidamide). CAS No. 2170606-74-1. Molecular formula: C42H41FN8O2. Mole weight: 708.8. | |
| DB2313 HCl | DB2313 is a potent inhibitor of the essential transcriptional factor PU.1 with IC50 value of 14 nM. Synonyms: DB2313 hydrochloride; DB 2313 hydrochloride; DB-2313 hydrochloride; DB2313 tetrahydrochloride; DB 2313 HCl; DB-2313 HCl. CAS No. 2170606-75-2. Molecular formula: C42H45Cl4FN8O2. Mole weight: 854.7. | |
| DB818 | DB818 is a synthetic HOXA9 inhibitor that downregulates the expression of HOXA9 transcriptional target genes. Synonyms: DB 818; DB-818. Grade: >98%. CAS No. 790241-43-9. Molecular formula: C19H16N6S. Mole weight: 360.44. | |
| DB-cAMP-AM | DB-cAMP-AM is a precursor of DB-cAMP. The dibutyryl cAMP is released after the metabolism of DB-cAMP-AM by esterases. Grade: ≥ 97% by HPLC for mixture of isomers. CAS No. 159910-48-2. Molecular formula: C21H28N5O10P. Mole weight: 541.5. | |
| DB-cCMP | DB-cCMP is a membrane-permeant prodrug of cCMP, the potential further second messenger. Synonyms: N4, 2'- O- Dibutyrylcytidine- 3', 5'- cyclic monophosphate, sodium salt. Grade: ≥ 97 % by HPLC. CAS No. 64649-87-2. Molecular formula: C17H23N3O9P · Na. Mole weight: 467.3. | |
| DB-cGMP | DB-cGMP, an exceedingly compelling analogue of cyclic guanosine monophosphate (cGMP), a pivotal secondary messenger in myriad biological processes, serves as an invaluable tool in biomedical research. With a primary focus on unraveling the intricate role of cGMP in signal transduction pathways, cellular proliferation, and apoptosis, it facilitates the understanding of diseases stemming from aberrant cGMP signaling. Synonyms: N2, 2'- O- Dibutyrylguanosine- 3', 5'- cyclic monophosphate, sodium salt. Grade: ≥ 97% by HPLC. CAS No. 51116-00-8. Molecular formula: C18H23N5O9P · Na. Mole weight: 507.4. | |
| DBCO-dT CE Phosphoramidite | DBCO-dT CE Phosphoramidite is a copper-free click chemistry reagent designed for site-specific incorporation of dibenzocyclooctyne (DBCO) into oligonucleotides during solid-phase synthesis, enabling bioorthogonal conjugation with azide-functionalized molecules. The reagent features a DBCO moiety linked to a deoxythymidine (dT) base via a spacer arm, with a 3'-phosphoramidite group for efficient coupling in automated synthesizers. This phosphoramidite is ideal for preparing molecular probes, diagnostic assays, or therapeutic oligonucleotides requiring post-synthesis labeling. Synonyms: DBCO-dT Phosphoramidite. Grade: ≥95%. Molecular formula: C69H80N7O11P. Mole weight: 1214.41. | |
| DBCO-Serinol Phosphoramidite | DBCO-Serinol Phosphoramidite is a quintessential reagent for biomedical research, a chemical compound that is omnipresent in the lab benches of esteemed molecular biologists. This versatile oligonucleotide synthesizer is engineered to conjugate with various biomolecules for a plethora of drug delivery and bioimaging applications. Synonyms: 3-Dimethoxytrityloxy-2-(6-oxo-6-(dibenzo[b,f]azacyclooct-4-yn-1-yl)-capramido)propyl-1-O-(2-cyanoethyl)-(N,N-diisopropyl)-phosphoramidite. Molecular formula: C54H61N4O7P. Mole weight: 909.08. | |
| DBeQ | DBeQ inhibits p97 competitively with respect to ATP, with Ki of 3.2 μM, suggesting that it binds to the active site of the D2 domain. Synonyms: DBeQ; DBEQ; JRF12; JRF-12; JRF 12. Grade: >98%. CAS No. 177355-84-9. Molecular formula: C22H20N4. Mole weight: 340.42. | |
| DBG-3D diacid | DBG-3D diacid is an impurity of Dabigatran, an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. Synonyms: 4-(((5-((2-Carboxyethyl)(pyridin-2-yl)carbamoyl)-1-methyl-1H-benzo[d]imidazol-2-yl)methyl)amino)benzoic acid; Dabigatran Impurity 69. CAS No. 1253792-34-5. Molecular formula: C25H23N5O5. Mole weight: 473.49. | |
| DBIBB | DBIBB is a non-lipid agonist of LPA2 (EC50 = 0.10 μM) that is a G protein-coupled receptor which plays roles in protecting against radiation-induced cell death and it has no effect at other LPA receptor subtypes. Synonyms: 2-[[[4-(1,3-dioxo-1H-benz[de]isoquinolin-2(3H)-yl)butyl]amino]sulfonyl]-benzoic acid. Grade: ≥98%. CAS No. 1569309-92-7. Molecular formula: C23H20N2O6S. Mole weight: 452.5. | |
| DBM 1285 dihydrochloride | DBM 1285 dihydrochloride is a p38 MAPK inhibitor supressing p38 phosphorylation and LPS-induced TNF-α production in macrophages and in vivo. It was shown to attenuate zymosan-induced inflammation and adjuvant-induced arthritis in murine models. Synonyms: DBM 1285 dihydrochloride; DBM1285 dihydrochloride; DBM-1285 dihydrochloride; N-Cyclopropyl-4-[4-(4-fluorophenyl)-2-(4-piperidinyl)-5-thiazolyl]-2-pyrimidinamine dihydrochloride. Grade: ≥98% by HPLC. CAS No. 1782532-29-9. Molecular formula: C21H22FN5S.2HCl. Mole weight: 468.42. | |
| DBPR108 | DBPR108 is an IC50=15 nM DPP IV inhibitor displays a more than 3000-fold selectivity over DPP8 DPP9, FAP and DPP-II. TThe in vivo effects of DBPR108, including inhibition of plasma DPP-IV activity and suppression of blood glucose elevation, were also demonstrated. DBPR108 is a potent, selective, long-acting and safe DPP-IV inhibitor as a potential treatment of type 2 diabetes mellitus. Synonyms: DBPR-108; DBPR 108; DBPR108. Grade: >98%. CAS No. 1186426-66-3. Molecular formula: C16H25FN4O2. Mole weight: 324.39. | |
| DBPR112 | DBPR112 is an orally active EGFR inhibitor based on furanopyrimidine, with IC50s of 15 nM and 48 nM for EGFRWT and L858R/T790M, respectively. DBPR112 can occupy the ATP-binding site and has significant antitumor effects. Synonyms: 2-Butenamide, 4-(dimethylamino)-N-[3-[4-[[(1S)-2-hydroxy-1-phenylethyl]amino]-6-phenylfuro[2,3-d]pyrimidin-5-yl]phenyl]-, (2E)-; (S,E)-4-(dimethylamino)-N-(3-(4-((2-hydroxy-1-phenylethyl)amino)-6-phenylfuro[2,3-d]pyrimidin-5-yl)phenyl)but-2-enamide; (2E)-4-(Dimethylamino)-N-[3-(4-{[(1S)-2-hydroxy-1-phenylethyl]amino}-6-phenylfuro[2,3-d]pyrimidin-5-yl)phenyl]-2-butenamide. Grade: ≥98%. CAS No. 1226549-49-0. Molecular formula: C32H31N5O3. Mole weight: 533.62. | |
| D-Buthionine | D-Buthionine is an analog of Buthionine sulfoximine, which is a γ-glutamylcysteine synthetase inhibitor used to increase the sensitivity of parasites to oxidative antiparasitic drugs. Uses: (r)-homocysteine thioether. Synonyms: S-Butyl-D-homocysteine; D-2-Amino-4-(butylthio)butyric Acid; n-Butyl-D-homocysteine; D-Homocysteine, S-butyl-; (R)-2-Amino-4-(butylthio)butanoic acid. Grade: 95%. CAS No. 13073-22-8. Molecular formula: C8H17NO2S. Mole weight: 191.29. | |
| D-Buthionine-(S,R)-sulfoximine | D-Buthionine-(S,R)-sulfoximine is an analog of Buthionine sulfoximine, which is a γ-glutamylcysteine synthetase inhibitor used to increase the sensitivity of parasites to oxidative antiparasitic drugs. Uses: A potent and specific inhibitor of alpha-glutamylcysteine synthetase. Synonyms: (2R)-2-Amino-4-(S-butylsulfonimidoyl)butanoic Acid; (R)-Buthionine sulfoximine; (R)-2-amino-4-(S-butylsulfonimidoyl)butyric acid; Butanoic acid, 2-amino-4-(S-butylsulfonimidoyl)-, (2R)-; (R)-2-amino-4-((S,R)-butylsulfonimidoyl)butanoic acid. Grade: ≥90%. CAS No. 113158-69-3. Molecular formula: C8H18N2O3S. Mole weight: 222.30. | |
| DBZ | DBZ, also called dibenzazepine, is a γ-secretase inhibitor to treat Alzheimer's Disease, and it also inhibits Notch signaling. Synonyms: YO-01027; YO 01027; YO01027; (2S)-2-[[2-(3,5-difluorophenyl)acetyl]amino]-N-[(7S)-5-methyl-6-oxo-7H-benzo[d][1]benzazepin-7-yl]propanamide; dibenzazepine; GSI XX; Dibenzazepine; 209984-56-5; YO-01027; (S)-2-(2-(3,5-Difluorophenyl)acetamido)-N-((S)-5-methyl-6-oxo-6,7-dihydro-5H-dibenzo[b,d]azepin-7-yl)propanamide; Deshydroxy LY 411575; gamma-Secretase Inhibitor XX; DBZ; 209984-56-5 pound not YO 010. Grade: >98%. CAS No. 209984-56-5. Molecular formula: C26H23F2N3O3. Mole weight: 463.48. | |
| DC-009 | DC-009 is a small-molecule thrombolytic that can scavenge the free radical in cells. Studies in vitro and in vivo showed that DC-009 had the similar activity as recombinant tissue plasminogen activator (rt-PA) and dose-dependent activity. Further study of treating ischemic stroke is planned. Uses: The potential treatment of ischemic stroke. Synonyms: DC009; DC 009. | |
| DC-05 | DC-05 is a potent and selective non-nucleoside DNMT1 (DNA methyltransferase 1) inhibitor with IC50 of 10.3 uM. It has significant selectivity toward other AdoMet-dependent protein methyltransferases. It significantly inhibits cancer cell proliferation. It inhibitis DNMT1 by binding to DNMT1 instead of incorporating into DNA. Uses: Dc-05 inhibits cancer cell proliferation. Synonyms: DC-05; DC 05; DC05; 1-Carbazol-9-yl-3-[2-(1H-indol-3-yl)ethylamino]propan-2-ol. Grade: >98 %. CAS No. 890643-16-0. Molecular formula: C25H25N3O. Mole weight: 383.49. | |
| DC07090 dihydrochloride | DC07090 dihydrochloride is a potent, reversible, low toxicity and competitive non-peptide inhibitor of human enterovirus 71 3C protease with an IC50 and a Ki value of 21.72 μM and 23.29 μM. It also inhibits the replication of coxsackievirus A16 (CVA16) with an EC50 value of 27.76 μM. Synonyms: 2-Pyridinemethanamine, N-(4-oxazolo[4,5-b]pyridin-2-ylphenyl)-, hydrochloride (1:2); (4-[1,3]oxazolo[4,5-b]pyridin-2-ylphenyl)(pyridin-2-ylmethyl)amine dihydrochloride; (4-Oxazolo[4,5-b]pyridin-2-yl-phenyl)-pyridin-2-ylmethyl-amine Dihydrochloride. Grade: >98%. CAS No. 1158264-37-9. Molecular formula: C18H16Cl2N4O. Mole weight: 375.25. | |
| DC-120 | DC-120 is an ATP competitive AKT kinase inhibitor that suppressed proliferation and induced apoptosis in liver cancer cells both in vitro and in vivo. DC120 blocked the phosphorylation of downstream molecules in the AKT signal pathway in dose- and time-dependent manners both in vitro and in vivo. DC120 inhibits AKT activity in vitro with an EC(50) of 153 nM. DC120 at 20 mg/kg/day inhibited the CNE2 xenograft tumor growth with a treated group/control group ratio of 38.1%, accompanied by increasing terminal deoxynucleotidyl transferasedUTP nick-end labeling-positive cells in the tumor sample. Synonyms: DC-120; DC 120; DC120. Grade: 98%. CAS No. 1261080-40-3. Molecular formula: C18H18Cl2N6OS. Mole weight: 437.35. | |
| DC 260126 | DC 260126 is a free fatty acid receptor 1 (FFA1/GPR40) antagonist that decreases intracellular Ca2+ levels and suppresses palmitic acid potentiated glucose-stimulated insulin secretion in Min6 pancreatic β cells in vitro. It was shown to lower serum insulin levels, improve insulin sensitivity and reduces the rate of apoptotic pancreatic β cells in obese diabetic (db/db) rats. Synonyms: DC 260126; DC260126; DC-260126; N-(4-Butylphenyl)-4-fluorobenzenesulfonamide. Grade: ≥98% by HPLC. CAS No. 346692-04-4. Molecular formula: C16H18FNO2S. Mole weight: 307.38. | |
| DC41 | DC41 is a DC1 derivative. DC1, a simplified analogue of CC-1065, is an antibody conjugate of cytotoxic DNA alkylators for the targeted treatment of cancer. Synonyms: DC41; 1354787-69-1; AKOS040732937; HY-112901; CS-0067648; N-{2-[(1S)-1-(chloromethyl)-5-hydroxy-1H,2H,3H-benzo[e]indole-3-carbonyl]-1H-indol-5-yl}-5-(4-methyl-4-sulfanylpentanamido)-1H-indole-2-carboxamide. CAS No. 1354787-69-1. Molecular formula: C37H34ClN5O4S. Mole weight: 680.21. | |
| DC41-SMe | DC41SMe, a DC1 derivative, shows cytotoxicity in Ramos, Namalwa, and HL60/s cells with IC50s ranging from 18-25 pM. DC1, a simplified analogue of CC-1065, is an antibody conjugate of cytotoxic DNA alkylators for the targeted treatment of cancer. CAS No. 1354787-71-5. Molecular formula: C38H36ClN5O4S2. Mole weight: 726.31. | |
| DC_517 | DC_517 is a novel selective non-nucleoside inhibitor of DNMT1. (IC50 = 1.7 μM), was found to be more potent than DC_05. Uses: A novel selective non-nucleoside inhibitor. Synonyms: DC-517; DC 517; DC517; 1-{[1,3-Di(9H-carbazol-9-yl)-2-propanyl]oxy}-3-(isopropylamino)-2-propanol. Grade: ≥98%. CAS No. 500017-70-9. Molecular formula: C33H35N3O2. Mole weight: 505.65. | |
| DC661 | DC661 is an effective palmitoyl-protein thioesterase 1 (PPT1) inhibitor that inhibits autophagy and ACTS as an antilysosomal agent. Compared with hydroxychloroquine (HCQ), DC661 has significant acid hydrolysis and autophagy inhibition. Synonyms: DC661; 1872387-43-3; N-(7-chloroquinolin-4-yl)-N'-[6-[(7-chloroquinolin-4-yl)amino]hexyl]-N'-methylhexane-1,6-diamine; N1-(7-chloroquinolin-4-yl)-N6-(6-((7-chloroquinolin-4-yl)amino)hexyl)-N6-methylhexane-1,6-diamine; dc-661; C31H39Cl2N5; CHEMBL4873725; SCHEMBL19399303; BCP30743; EX-A2963; XZC38743; s8808; ZB1540; AKOS037649041; DC-661; DC 661; AC-35596; BS-16368; HY-111621; CS-0088759; D80814; 7-chloro-N-[6-({6-[(7-chloroquinolin-4-yl)amino]hexyl}(methyl)amino)hexyl]quinolin-4-amine. CAS No. 1872387-43-3. Molecular formula: C31H39Cl2N5. Mole weight: 552.58. | |
| DC 838 | DC 838 is a potent human cyclophilin A (CypA) inhibitor. Synonyms: DC 838; DC838; DC-838; 1-N-[2,3-bis(furan-2-yl)quinoxalin-6-yl]-3-N,3-N-diethylpiperidine-1,3-dicarboxamide. Grade: 99%. CAS No. 508186-08-1. Molecular formula: C27H29N5O4. Mole weight: 487.55. | |
| DCA | DCA is a mitochondrial pyruvate dehydrogenase kinase (PDK) inhibitor that shifts pyruvate metabolism from glycolysis and lactate production to glucose oxidation in the mitochondria. DCA also induces apoptosis and reverses the KV1.5 channels downregulation in cancer. Synonyms: Sodium dichloroacetate; Sodium 2,2-dichloroacetate; Dichloroacetic acid sodium salt. CAS No. 2156-56-1. Molecular formula: C2HCl2NaO2. Mole weight: 150.92. | |
| dC(Ac)-3'-PS Phosphoramidite | dC(Ac)-3'-PS Phosphoramidite is a cytidine-derived phosphoramidite designed for the synthesis of oligonucleotides containing a 3'-phosphorothioate (PS) linkage. The 3'-PS modification replaces a non-bridging oxygen atom in the phosphate group with a sulfur atom, providing enhanced nuclease resistance and improved biological stability to the resulting oligonucleotides. The cytosine base is protected with an acetyl (Ac) group at the N4 position to prevent unwanted side reactions during synthesis. This phosphoramidite is widely used in therapeutic applications, such as antisense oligonucleotides and siRNA, where increased stability, resistance to enzymatic degradation, and prolonged activity are critical for performance. Synonyms: 5'-DMT-dC(Ac)-3'-PS-Phosphoramidite; Cytidine, N-Acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, 3'-[S-[2-(benzoylthio)ethyl] P-1-pyrrolidinylphosphonothioite]; Cytidine, N-Acetyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, 3'-[S-[2-(benzoylthio)ethyl] 1-pyrrolidinylphosphonothioite]; dC(Ac) ThioPhosphamidite. Grade: ≥90%. Molecular formula: C45H49N4O8PS2. Mole weight: 869.00. | |
| dC(Ac)-CE-Reverse Phosphoramidite | dC(Ac)-CE-Reverse Phosphoramidite is a cytidine-derived phosphoramidite designed for the reverse incorporation of nucleotides during oligonucleotide synthesis. It features a 3'-cyanoethyl (CE) phosphoramidite group at the 5'-position, enabling the addition of nucleotides in the reverse (3'→5') direction instead of the conventional 5'→3' direction. The cytosine base is protected with an acetyl (Ac) group at the N4 position to prevent side reactions during synthesis. This reverse phosphoramidite is commonly used for specialized oligonucleotide designs, such as branched structures, probes, and complex synthetic constructs, where reverse polarity is required for functionality or stability. Synonyms: 3'-DMT-dC(Ac)-CE Reverse; Cytidine, N-acetyl-3'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, 5'-[2-cyanoethyl N,N-bis(1-methylethyl)phosphoramidite]; N4-Acetyl-3'-O-(4,4'-dimethoxytrityl)-2'-deoxycytidine-5'-cyanoethyl phosphoramidite; ((2R,3S,5R)-5-(4-Acetamido-2-oxopyrimidin-1(2H)-yl)-3-(bis(4-methoxyphenyl)(phenyl)methoxy)tetrahydrofuran-2-yl)methyl (2-cyanoethyl) diisopropylphosphoramidite; 3'-O-DMTr-dC(Ac)-CE-Reverse-Phosphoramidite; DNA C(Ac) 3'-DMTr 5'-amidite. Grade: ≥98%. CAS No. 1632243-18-5. Molecular formula: C41H50N5O8P. Mole weight: 771.84. | |
| DCB | DCB is an allosteric ligand for the metabotropic glutamate receptor mGlu5 that displays neutral modulation. It inhibits the modulation of mGlu5 by other allosteric modulators without affecting agonist-stimulated mGlu5 responses. Synonyms: [(3-Chlorophenyl)methylene]hydrazone-3-chlorobenzaldehyde; (E,E)-Bis[(3-chlorophenyl)methylidene]hydrazine. Grade: ≥98% by HPLC. CAS No. 6971-97-7. Molecular formula: C14H10Cl2N2. Mole weight: 277.15. | |
| dC(Bz)-3'-PS Phosphoramidite | dC(Bz)-3'-PS Phosphoramidite is a cytidine-derived phosphoramidite used for synthesizing oligonucleotides containing a 3'-phosphorothioate (PS) linkage. The 3'-PS modification replaces a non-bridging oxygen atom in the phosphate group with a sulfur atom, enhancing the nuclease resistance and biological stability of the resulting oligonucleotides. The cytosine base is protected with a benzoyl (Bz) group at the N4 position to prevent side reactions during synthesis. This phosphoramidite is particularly useful in therapeutic oligonucleotides, such as antisense and siRNA applications, where improved stability, enzymatic resistance, and prolonged biological activity are essential. Synonyms: Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, 3'-[S-[2-(benzoylthio)ethyl] P-1-pyrrolidinylphosphonothioite]; Cytidine, N-benzoyl-5'-O-[bis(4-methoxyphenyl)phenylmethyl]-2'-deoxy-, 3'-[S-[2-(benzoylthio)ethyl] 1-pyrrolidinylphosphonothioite]; dC(Bz) ThioPhosphamidite; 5'-DMT-dC(Bz)-3'-PS-Phosphoramidite. Grade: ≥90%. CAS No. 178272-25-8. Molecular formula: C50H51N4O8PS2. Mole weight: 931.07. | |
| DCC-2618 | DCC-2618 inhibits normal and mutant KIT kinase at the nanomol level. The targets are wt c-KIT, c-KIT mutants, PDGFR alpha, PDGFR beta, KDR and cFMS. DCC-2618 inhibits mutant KIT in GIST patient cell line (GIST T1 pKIT western Ex11 deletion) at a IC 50 of 2 nM. Deciphera's technology has identified DCC-2618 as a molecule which can be developed as second line therapy for imatinib and sunitinib resistant GIST patients with the potential to progress to frontline GIST therapy. DCC-2618 has been designed to effectively inhibit the imatinib and sunitinib-sensitive KIT juxtamembrane domain mutants (JMD) as well as secondary resistant KIT kinase-domain mutants. DCC-2618 additionally targets PDGFR alpha oncogenic mutants. Synonyms: DCC2618; DCC 2618; c-Kit-IN-1; PDGFR inhibitor 1; N-[2,5-Difluoro-4-[[2-(1-methyl-1H-pyrazol-4-yl)-4-pyridinyl]oxy]phenyl]-N'-phenyl-1,1-cyclopropanedicarboxamide. Grade: >98%. CAS No. 1225278-16-9. Molecular formula: C26H21F2N5O3. Mole weight: 489.47. | |
| DC_C66 | DC_C66 is a selective and cell-permeable coactivator associated arginine methyltransferase 1 (CARM1) inhibitor with an IC50 of 1.8 μM. It shows good selectivity for CARM1 against PRMT1 (IC50 = 21 μM), PRMT6 (IC50 = 47 μM) and PRMT5. Synonyms: 9-(ethoxycarbonyl)-11H,12H-dibenzo[f,h]isoquino[2,1-b]isoquinolinium; 9-(Ethoxycarbonyl)-11,12-dihydrodibenzo[f,h]isoquinolino[2,1-b]isoquinolinium; Benzo[a]phenanthro[9,10-g]quinolizinium, 9-(ethoxycarbonyl)-11,12-dihydro-. Grade: ≥95%. CAS No. 108181-00-6. Molecular formula: C28H22NO2+. Mole weight: 404.48. | |
| DCEBIO | DCEBIO is a Ca2+ sensitive K+ channel (SKCa) agonist stimulating Cl- secretion via activation of hKCa3.1 (IK1) potassium channels and activation of an apical Cl- conductance. Synonyms: 5,6-Dichloro-1-ethyl-1,3-dihydro-2H-benzimidazol-2-one; Dichloro-EBIO. Grade: ≥99% by HPLC. CAS No. 60563-36-2. Molecular formula: C9H8Cl2N2O. Mole weight: 231.08. | |
| D-Cellobial | D-Cellobial is an exquisite and groundbreaking compound profoundly employed for the research of assorted maladies, encompassing the intricate realms of cancer and diabetes. This prodigious asset acts as an unparalleled inhibitor, thwarting the nefarious activity of meticulously targeted enzymes intricately intertwined within the metabolic cascades. Synonyms: 1,5-Anhydro-2-deoxy-4-(O-b-D-glucopyranosyl)-D-arabino-hex-1-enitol; D-arabino-Hex-1-enitol, 1,5-anhydro-2-deoxy-4-O-beta-D-glucopyranosyl-; 1,2-Dideoxy-4-O-beta-D-glucopyranosyl-D-arabino-hex-1-enopyranose; D-cellobiosene. Grade: ≥98%. CAS No. 490-51-7. Molecular formula: C12H20O9. Mole weight: 308.28. | |
| D-Cellobionic acid, ammonium salt | D-Cellobionic acid, ammonium salt. Synonyms: Ammonium cellobionate; 4-O-β-D-glucopyranosyl-D-gluconic acid ammonium salt. Molecular formula: C12H25NO12. Mole weight: 375.30. | |
| D-Cellobionic acid, potassium salt | D-Cellobionic acid, potassium salt. Synonyms: Potassium cellobionate; 4-O-β-D-glucopyranosyl-D-gluconic acid potassium salt. Molecular formula: C12H21KO12. Mole weight: 396.39. | |
| D-Cellobiose | D-Cellobiose, an imperative disaccharide formed by coupling two glucose molecules, finds extensive utility in the biomedical sector. This compound assumes the role of a crucial substrate in enzyme assays, thereby facilitating their efficacy. Moreover, it serves as a vital carbon source for bacteria engrossed in the degradation of cellulose. Synonyms: Glc-b-1,4-Glc; 4-O-(b-D-Glucopyranosyl)-D-glucopyranose; 4-O-β-D-Glucopyranosyl-D-glucose; Glc1-b-4-D-Glc; D-(+)-Cellobiose; beta-maltose; 1-beta-D-Glucopyranosyl-4-D-glucopyranose; Glc(b1-4)aldehydo-Glc; Cellobiose; D-(+)-Cellobiose; Cellobiose 90; Cellose; Sun Cellobio K. Grade: ≥98%. CAS No. 528-50-7. Molecular formula: C12H22O11. Mole weight: 342.30. | |
| D-(+)-Cellobiose Octaacetate | D-(+)-Cellobiose Octaacetate is a compound often used in the biomedical industry serving as a precursor for various drugs development. Synonyms: D-Glucopyranose, 4-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-, 1,2,3,6-tetraacetate; 4-O-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl)-D-glucopyranose 1,2,3,6-Tetraacetate; Octa-O-acetylcellobiose; Octaacetyl-D-cellobiose; Cellobiose Octaacetate. Grade: 98%. CAS No. 3616-19-1. Molecular formula: C28H38O19. Mole weight: 678.59. | |
| D-Cellobiosyl trichloroacetimidate heptaacetate | D-Cellobiosyl trichloroacetimidate heptaacetate. Synonyms: D-Glucopyranose, 4-O-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)-, 2,3,6-triacetate 1-(2,2,2-trichloroethanimidate); 2,3,6,2',3',4',6'-Hepta-O-acetyl-1-O-trichloroacetimidoyl-D-cellobioside; 2,3,6,2',3',4',6'-Hepta-O-acetyl-D-cellobiosyl trichloroacetimidate; 4-O-(2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl)-D-glucopyranose 2,3,6-triacetate 1-(2,2,2-trichloroethanimidate). Grade: ≥97%. CAS No. 250330-69-9. Molecular formula: C28H36Cl3NO18. Mole weight: 780.94. | |
| D-Celloheptaose | D-Celloheptaose, a carbohydrate-derived compound, is an assemblage of precisely linked seven glucose units. It used in the research of deciphering the intricate interplay between saccharides and maladies such as diabetes, cancer and microbial infestations. Synonyms: Celloheptaose; O-β-D-Glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→4)-D-glucose; Glc(b1-4)Glc(b1-4)Glc(b1-4)Glc(b1-4)Glc(b1-4)Glc(b1-4)aldehydo-Glc. CAS No. 52646-27-2. Molecular formula: C42H72O36. Mole weight: 1153.02. | |
| D-Cellohexaose | D-Cellohexaose is an intricate carbohydrate compound highly prevalent in the biomedical sector assuming a pivotal function in examining intricate intercellular communications, intricate cellular signaling and complex drug transportation systems. Synonyms: Cellohexaose; O-β-D-Glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→4)-O-β-D-glucopyranosyl-(1→4)-D-glucose. CAS No. 2478-35-5. Molecular formula: C36H62O31. Mole weight: 990.86. | |
| D-Cellohexose eicosaacetate | D-Cellohexose eicosaacetate is an innovative biomedical substance, functioning as a specialized enzyme inhibitor. It is used for studying diabetes, cancer and inflammatory disorders. Uses: Indicators and reagents. Synonyms: O-2,3,4,6-Tetra-O-acetyl-b-D-glucopyranosyl-(1-4)-O-2,3,6-tri-O-acetyl-b-D-glucopyranosyl-(1-4)-O-2,3,6-tri-O-acetyl-b-D-glucopyranosyl-(1-4)-O-2,3,6-tri-O-acetyl-b-D-glucopyranosyl-(1-4)-O-2,3,6-tri-O-acetyl-b-D-glucopyranosyl-(1-4)-D-glucopyranose tetraacetate; D-Glucopyranose, O-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-(1→4)-O-2,3,6-tri-O-acetyl-β-D-glucopyranosyl-(1→4)-O-2,3,6-tri-O-acetyl-β-D-glucopyranosyl-(1→4)-O-2,3,6-tri-O-acetyl-β-D-glucopyranosyl-(1→4)-O-2,3,6-tri-O-acetyl-β-D-glucopyranosyl-(1→4)-, tetraacetate. CAS No. 355012-91-8. Molecular formula: C76H102O51. Mole weight: 1831.59. | |
| D-Cellopentaose | D-Cellopentaose is a carbohydrate used in the biomedical industry with potential antibacterial properties, the ability to inhibit biofilm formation, and the potential to treat bacterial infections, primarily Streptococcus mutans. Synonyms: 1,4-β-D-Cellopentaose; D-(+)-Cellopentaose; O-β-D-Glucopyranosyl-(1-4)-O-β-D-glucopyranosyl-(1-4)-O-β-D-glucopyranosyl-(1-4)-O-β-D-glucopyranosyl-(1-4)-D-glucose; (Glc1-b-4)4-D-Glc; β-D-Glc-[1->4])4-D-Glc; β-D-Glucopyranosyl-(1->4)-β-D-glucopyranosyl-(1->4)-β-D-glucopyranosyl-(1->4)-β-D-glucopyranosyl-(1->4)-D-glucose; Cellopentaose. Grade: ≥95%. CAS No. 2240-27-9. Molecular formula: C30H52O26. Mole weight: 828.72. | |
| D-Cellopentose heptadecaacetate | D-Cellopentose heptadecaacetate, an extensively utilized compound in the biomedicine field, exhibits immense potential in addressing diverse ailments like cancer and viral infections. The compound's extraordinary chemical configuration enables precise administration and improved bioavailability of therapeutic agents. Synonyms: Cellopentaose heptadecaacetate; D-Glucopyranose, O-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-(1→4)-O-2,3,6-tri-O-acetyl-β-D-glucopyranosyl-(1→4)-O-2,3,6-tri-O-acetyl-β-D-glucopyranosyl-(1→4)-O-2,3,6-tri-O-acetyl-β-D-glucopyranosyl-(1→4)-, tetraacetate. CAS No. 83058-38-2. Molecular formula: C64H86O43. Mole weight: 1543.34. | |
| D-Cellopentose Hexadecaacetate | D-Cellopentose Hexadecaacetate is an elusive metabolite sourced from D-Cellopentose, showcasing exceptional applications in studying a myriad of diseases, including diabetes and cancer. Synonyms: O-2,3,4,6-Tetra-O-acetyl-β-D-glucopyranosyl-(1→4)-O-2,3,6-tri-O-acetyl-β-D-glucopyranosyl-(1→4)-O-2,3,6-tri-O-acetyl-β-D-glucopyranosyl-(1→4)-O-2,3,6-tri-O-acetyl-β-D-glucopyranosyl-(1→4)-D-glucopyranose, 2,3,6-triacetate. Molecular formula: C62H84O42. Mole weight: 1501.31. | |
| D-Cellotetraose | D-Cellotetraose, a carbohydrate molecule, has been identified as a promising prebiotic for stimulating the growth of beneficial gut bacteria. Research suggests it may even hold potential as a therapeutic agent for inflammatory bowel diseases. With its multifaceted applications in biomedicine, this compound is surely an indispensable asset to the scientific community. Synonyms: Cellotetraose; (Glc-b-1,4)3-Glc; D-(+)-Cellotetraose; O-β-D-Glucopyranosyl-(1-4)-O-β-D-glucopyranosyl-(1-4)-O-β-D-glucopyranosyl-(1-4)-D-glucose; (Glc1-b-4)3-D-Glc; beta-D-Glcp-(1->4)-beta-D-Glcp-(1->4)-beta-D-Glcp-(1->4)-D-Glcp; beta-D-glucopyranosyl-(1->4)-beta-D-glucoopyranosyl-(1->4)-beta-D-glucoopyranosyl-(1->4)-D-glucoopyranose. Grade: ≥95%. CAS No. 38819-01-1. Molecular formula: C24H42O21. Mole weight: 666.58. | |
| D-Cellotetraose tetradecaacetate | D-Cellotetraose tetradecaacetate, an extraordinary biomedical compound, garners enormous attention in the realm of pharmaceutical investigation and advancement. This intricate structure unveils auspicious attributes, rendering it a formidable contender in the combat against a plethora of afflictions, encompassing malignancies, diabetes, and inflammatory maladies. Synonyms: D-Glucopyranose, O-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-(1→4)-O-2,3,6-tri-O-acetyl-β-D-glucopyranosyl-(1→4)-O-2,3,6-tri-O-acetyl-β-D-glucopyranosyl-(1→4)-, tetraacetate; D-Glucopyranose, O-2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl-(1→4)-O-2,3,6-tri-O-acetyl-β-D-glucopyranosyl-(1→4)-O-2,3,6-tri-O-acetyl-β-D-glucopyranosyl-(1→4)-, 1,2,3,6-tetraacetate; Cellotetraose tetradecaacetate; Cellotetraose peracetate; D-(+)-Cellotetraose Tetradecaacetate. CAS No. 83058-25-7. Molecular formula: C52H70O35. Mole weight: 1255.09. | |
Our database is helping our users find suppliers everyday.
